GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (STU:6ML0) » Definitions » Market Cap

Molecular Partners AG (STU:6ML0) Market Cap : €114.39 Mil (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Molecular Partners AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Molecular Partners AG's share price for the quarter that ended in Mar. 2024 was €3.5. Molecular Partners AG's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 32.87 Mil. Therefore, Molecular Partners AG's market cap for the quarter that ended in Mar. 2024 was €115.04 Mil.

Molecular Partners AG's quarterly market cap increased from Sep. 2023 (€120.18 Mil) to Dec. 2023 (€124.19 Mil) but then declined from Dec. 2023 (€124.19 Mil) to Mar. 2024 (€115.04 Mil).

Molecular Partners AG's annual market cap declined from Dec. 2021 (€565.12 Mil) to Dec. 2022 (€200.05 Mil) and declined from Dec. 2022 (€200.05 Mil) to Dec. 2023 (€124.19 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Molecular Partners AG's Enterprise Value for Today is €-70.64 Mil.


Molecular Partners AG Market Cap Historical Data

The historical data trend for Molecular Partners AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Market Cap Chart

Molecular Partners AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 565.12 200.05 124.19

Molecular Partners AG Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 179.06 183.85 120.18 124.19 115.04

Competitive Comparison of Molecular Partners AG's Market Cap

For the Biotechnology subindustry, Molecular Partners AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Partners AG's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Partners AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Molecular Partners AG's Market Cap falls into.



Molecular Partners AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Molecular Partners AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€3.78*32.8543
=€124.19

Molecular Partners AG's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=€3.5*32.869
=€115.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Partners AG  (STU:6ML0) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Molecular Partners AG Market Cap Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Partners AG (STU:6ML0) Business Description

Traded in Other Exchanges
Address
Wagistrasse 14, Schlieren, Zurich, CHE, 8952
Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Molecular Partners AG (STU:6ML0) Headlines

No Headlines